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White vulva! skin lesions may be due to various conditions, including benign and
non-benign causes. The dilemma faced by the clinician with such a patient is the
aetiology of the lesion, as well as the approach to management.
AIM
To establish the aetiology of white vulva! skin lesions in patients attending the
gynaecology clinic and to evaluate the role of Collin's test and vulvoscopy.
SETTING
R. K. Khan Hospital, which is a secondary level hospital in Durban, KwaZulu Natal.
METHOD
Sixty-two patients with white vulva! skin lesions whom consented to the study were
recruited. The investigations consisted of Pap smear, colposcopy of the vulva
[Vulvoscopy], perineum and where appropriate, vaginoscopy and colposcopy;
Collin's test and biopsy of all abnormal areas detected by these tests.
v
RESULTS
Pruritus vulvae was the commonest presenting symptom [70%1. No vulvoscopic
abnormalities were detected in 97% of patients, whilst 3% had acetowhite areas
indicative of Human papilloma virus infection. Collin's test was positive in 40% of
patients, although, histologically these areas were benign. All patients in the study
had benign lesions on histology.
CONCLUSION
All patients in this study had benign causes of white vulval skin lesions. However,
this cannot lead us to conclude that there is no role for doing Vulvoscopy and
Collin's test, as premalignant and malignant lesions should be detected by these tests
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One of the commonest symptoms of vulva! diseases is pruritus vulvae. [11 It
has also been shown to be one of the commonest symptoms for which
women attend a gynaecological clinic.E 2' 3' 451 Another important symptom is
that of vulva! pain [Vulvodynia]. Vulvodynia is defined as chronic vulva!
discomfort, characterized by the patient's complaint of burning, and
sometimes stinging, irritation and rawness. [61 There are various clinical
entities, which constitute the syndrome of vulvodynia [71 viz. vulva!
dermatoses, cyclic vulvitis, vulvovestibulitis syndrome, essential or
dysaesthetic vulvodynia; vulval papillomatosis and miscellaneous causes such
as neuroma of the vulva. [81
There are many causes of pruritus vulvae. Examples include infections such
as candidiasis, diabetes mellitus, hepatic or biliary disease, haematological
conditions like polycythemia, systemic dermatoses, amongst others.
Although some authors [91 differentiate between pruritus and vulvodynia, the
sensations of itching and pain respectively, are conducted by the
unmyelinated type C nerve fibres. The stimuli for both these sensations
however, are quite different. It is therefore important to examine these
patients thoroughly to look for precipitating factors and to establish the
cause. The patient with "Burning Vulva Syndrome" [101 seldom has gross
abnormal physical findings. Dermatological manifestations of vulva! disease
2
may be confusing, the cause may be ambiguous and the course of treatment
usually long and frustrating. If the patient does not complain of a specific
vulval symptom, the vulva is often overlooked during a routine
gynaecological examination and is often simply "the means to go through" in
order to perform the routine digital examination or pap smear.
A systematic approach to establish the aetiology of the patients'
symptomatology is necessary. Various authors 
[9,11,12,13,14] 
have advocated an
approach, which includes a thorough physical examination, pap smear,
colposcopy of the vulva, vagina, cervix and perineum, Collin's test and
biopsy of all abnormal areas detected by these tests. The role and need to do
these tests have been questioned, since there are both false negatives and
false positives associated with colposcopy [151 and Collin's test [161 . If a
macroscopic lesion is present, the difficulty then, is to decide on which areas
to biopsy in order to establish diagnosis.
Lesions found macroscopically and at colposcopy are classified according to
the classification of Friedrich et al [171 [1983], in accordance with their
appearance, white lesions, red lesions, dark lesions, ulcers, small tumours or
large tumours. Many patients present with white vulva! skin lesions, the cause
of which varies from benign to malignant. Thus, in order to establish a
correct diagnosis, a biopsy is necessary from the representative area. The
3
issue therefore is to decide on which area is the most representative. The
limitations of the above mentioned investigations are noted and the emphasis
of the study are the causes as well as evaluation of these investigations in-
patients with white vulval skin lesions.
2. HISTORICAL PERSPECTIVES AND TERMINOLOGY OF WHITE
VULVAL SKIN LESIONS
2.1 PREVIOUS TERMINOLOGY
The earliest description of a white vulva! skin lesion was recorded by Weir [181
et al [1875]. He noted that these lesions were persistent, pruritic and
benign. This case was presented among cases of leucoplakia of the tongue, a
lesion recognized as premalignant. The issue of natural progression and
especially the malignant potential of these lesions have been raised many
times since, often, with an accompanying plea for a change in terminology.
Schwimmer [191 et al [1877] used the term "leucoplakia", which implied a
potentially malignant change in mucosal and mucocutaneous tissue. The
word "leucoplakia" is derived from leucos - white and placos — a flat plate.
It was first used in medicine to denote a skin condition, which is
characterized by a naked eye appearance of "white plaques" and was applied
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originally to the tongue and mouth. This term was not intended to denote
anything more than a clinical picture of white plaques, the plaques
representing an increased deposition of keratin on the skin surface. Beneath
this keratin various histological changes in the epidermis and dermis were
described, with the possibility of there being two directly opposing features —
namely, hypertrophy and atrophy.
Breiskyl'l et al [1885] introduced the term "Kraurosis" which means
brittle. Yet, various authors later had different interpretations of this term.
Taussig 
[211
 et al [1922] regarded the term Kraurosis as meaning
"shrinkage", while Hunt 
[221
 et al [1940] regarded this term as meaning
"white and dry".The British and American opinion on this term was also
divided. The British view followed the teachings of Berkeley and Bonney [231
et al [1909] as a condition affecting only the introitus, causing contracture
and therefore dyspareunia, rather than pruritus. This concept was never
accepted outside Great Britain. Taussig regarded contracture of the introitus
merely as a result of excessive degenerative changes in the epidermis and
dermis. The term Kraurosis is now recognized as lichen sclerosus.
Hallopeau 1251 et al [1889] described a condition of unknown aetiology in
which there were small white patches of skin associated with atrophy of the
vulva! and perianal skin. This lesion was termed lichen sclerosus and has
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survived all the changes in the literature over the past 100 years, in spite of
the fact that there is neither lichen nor sclerosus present! "Lichen" implies
thickening, yet the skin in this condition is thin and "Sclerosus" implies
metabolic inactivity, yet several classic studies have proven that the tissue is
indeed metabolically active, normal skin: " 7' 26] Lichen sclerosus was also
called lichen sclerosus et atrophicus. The terms "et atrophicus" is no longer




 et al [1922] introduced the term Leukoplakic vulvitis, a
description of which was later recognized as mixed dystrophy [Lichen
sclerosus with associated hyperplasia]. Taussig 1211et al [1922] further
distinguished leukoplakic vulvitis from kraurosis not only on the basis of
appearance and histology, but also on that of prognosis, stating that in his
experience simple kraurosis had no malignant potential, while 50% of
leukoplakic vulvitis progressed to malignancy. 
[21,27,28]
2.2 LATER CORRELATIONS
Wallace et al 12911951] and Wallace 
[30]
 [1955] in a series of accounts
summarized by Wallace 
[31]
	attempted to overcome the confusion
surrounding leukoplakia, kraurosis and leukoplakic vulvitis and their relation
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to lichen sclerosus. They proposed that those cases clearly showing typical
lichen sclerosus, clinically and histologically, should be noted as such. The
terms Kraurosis and leukoplakic vulvitis should be dropped and where
Kraurosis was seen without clear evidence of lichen sclerosus, this should be
called " Primary Atrophy." Primary atrophy was regarded as having some
potential for malignant change. Further, whereas Berkeley and Bonney 
[231
 et
al [ 1909] had found no hyalinization histologically, but much inflammation,
the histology of primary atrophy was described by Wallace and Whimster [291
[1951]et al as an atrophic epidermis, reduced elastic tissue, hyalinised
collagen and some inflammatory cells. They retained the term Leukoplakia as
a histological entity, characterized by marked dermal hyalinization,
sometimes a dermal infiltrate, a hyperkeratotic epidermis with lengthened,
irregular forked rete pegs with or without cellular atypia.
Jeffcoate 
[321
 et al [1961] tried to simplify the situation, beginning with an
analysis of all putative causes of vulva! malignancy. They reviewed the terms
Leukoplakia and leukoplakic vulvitis and noted that in many situations the
clinician expected the histopathologist to provide the diagnosis of leukoplakia
and vice versa. They also noted that there were no clinical differences
between leukoplakia, kraurosis and lichen sclerosus. They concluded that the
same end point occurs due to different aetiological factors and that the
vulval and perianal regions are subject to chronic skin changes, probably
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conditioned by environment rather than causes. These skin changes
irrespective of their appearances, for which a specific cause is unknown, are
best given clinically by an all-embracing term such as "Chronic Epithelial
Dystrophy."
Gardner et al 
[33]
 [1969] suggested a histopathological classification with
terms like Atrophic Dystrophy [Lichen Sclerosus], Hyperplastic Dystrophy
and mixed Dystrophy [lichen sclerosus with foci of epithelial hyperplasia].
The sixth world congress of the International Federation Of Obstetricians
and Gynaecologists was held in 1970, at which Gardner led a round table
discussion of vulva! diseases. From the efforts of those present, the
International Society for The Study of Vulva! Diseases [ISSVD] was formed.
The purpose of this society included the classification, study and sharing of
ideas and facts related to vulva! diseases. It's members included
gynaecologists, pathologists and dermatologists.
Friedrich et al 
[33,341
 [1976], reporting on behalf of the International Society
for the Study of Vulvar Disease, recommended that lichen sclerosus et
atrophicus, leukoplakia, neuro dermatitis, leukeratosis, Bowen's disease,
erythroplasia of Queyrat, Carcinoma simplex, leukoplakic vulvitis,
hyperplastic vulvitis and kraurosis vulvae be deleted from the vocabulary of
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vulvar diseases. Recommendations were made for an appropriate
classification as follows:
i. Hyperplastic Dystrophy — with / without Atypia
IL Lichen sclerosus
iii. Mixed Dystrophy — with / without Atypia.
Mixed dystrophy referred to lichen sclerosus with foci of epithelial
hyperplasia. A uniform terminology to facilitate the collection and analysis
of data on these diseases was thus developed. This classification is strictly
histopathological, while the only clinical correlate is to note if the lesions
were diffuse or localized, thick or thin, white or red.
2.2 THE CURRENT POSITION
Judging from the accounts of Berkeley and Bonney [231 et al [ 1909], the
terms Kraurosis and Leukoplakic vulvitis are, essentially unitary and fully
compatible with the different patterns of Lichen sclerosus. The same is true
of the descriptions by Taussig [211 et al [1922] of these two terms. On
reviewing the clinical and histological findings of primary atrophy, it was
found that many patients with primary atrophy developed unequivocal lichen
sclerosus. Therefore the use of the term primary atrophy has fallen away.
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It was found that the entity "leukoplakia" corresponds to an active, painful
fissured lesion of lichen sclerosus and is therefore regarded as a severe phase
of lichen sclerosus. This term, presently, is reserved for use for oral lesions,
at the recommendation of the World Health Organization 1351 and is defined
as a white patch or plaque that cannot be characterized clinically or
pathologically as any other disease. Thus, this term has been restored to its
original oral domain and is no longer used to describe lesions on the vulva.
On reviewing the term "Dystrophy" it is noted that it comes from "dys"
which means bad or difficult and "trophe" which relates to the nutrition or
vascularity of the tissue. Yet, there are no proven nutritional or vascular
aberrations present. It was also recognized that well-defined entities like
psoriasis or eczema should have been recognized separately. The most
problematic situation was when the term "atypia" was used as it frequently
led many gynaecologists to radical vulva! surgery or radiotherapy with its
attendant problems in a condition of unknown malignant potential.
At the Ninth Congress of the International Society for the study of vulva!
diseases in 1987 1'1, changes were made in conjunction with the
International Society of Gynaecological Pathologists, regarding terminology
and classification. It was recommended that the terms "et atrophicus" be
1 0
dropped in patients with lichen scierosus, as it has been shown that the
epithelium is indeed metabolically active. The term Dystrophy has been
replaced by the terms "Dermatoses" or "non-neoplastic epithelial vulva!
disorders"[NNEVD], emphasizing its non-neoplastic or benign nature. The
term atypia is no longer used and where atypia is present, it is now grouped
with the vulva! intraepithelial neoplastic [VIN] lesions. The term
hyperplastic dystrophy has been replaced by the term squamous cell
hyperplasia. The term mixed dystrophy is no longer used as it has been
recognized that lichen scierosus may have a hyperplastic component without
necessarily implying the presence of another disease entity.
Specific lesions or dermatoses affecting the vulva [e.g. psoriasis, lichen
simplex chronicus, lichen planus, contact dermatitis, etc] would be
specifically diagnosed and included under the term "other dermatoses". The
current classification of the vulva! dermatoses is therefore:
i. Lichen Sclerosus
ii. Squamous Cell Hyperplasia
ill. Other Dermatoses
11
Examples of other dermatoses include:




2.3 CRITICISMS OF THE CURRENT TERMINOLOGY / CLASSIFICATION
There are two aspects of the current classification/terminology that are open
to criticism. 1371 Firstly, as noted, the term lichen sclerosus does not
appropriately describe the histological features. Yet, this term has survived
all attempts to simplify the terminology. The second contentious issue is the
term squamous cell hyperplasia, which was introduced to provide a
descriptive term acceptable to both clinicians and pathologists. This term is
not ideal, as epithelial hyperplasia may be the end result of a number of
conditions. The diagnosis should be one of exclusion and should not be
given as a pathological diagnosis if there is a definable dermatoses or
pathological process which would explain the underlying process. There is
also a possibility that clinicians and pathologists may confuse the term with
12
lichen simplex chronicus, which has squamous cell hyperplasia as one of its
principle features.
3. CLASSIFICATION OF WHITE VULVAL SKIN LESIONS
Gross white appearance of vulval skin may be due to three general types of
change:
i. Absence or loss of pigment
ii. Increased keratinisation [Hyperkeratosis]
iii. Relative avascularity
The following classification [381 of white vulva! skin lesions is recommended:






2. Squamous cell hyperplasia
3. Other- Lichen simplex chronicus
- Lichen planus
D. Vulva! Intraepithelial neoplasia
E. Vulva! Paget's disease
F. Invasive vulva! carcinoma
13
3.1 DEPIGMENTATION DISORDERS
Depigmentation can occur if the basal layer melanocytes are lost or
destroyed or because of chemical malfunction, they are unable to synthesize
melanin pigment. Vitiligo or leukoderma may be due to congenital or
acquired absence of pigment. These terms are often used interchangeably.
The congenital variety often appears at the menarche suggesting a
relationship between pituitary gonadotropes and melanin stimulating
hormone. Many parts of the body may be involved, although the anogenital
area seems to be more common.
In the acquired type the melanocytes disappear from localized areas of skin.
Trauma, infection and radiation scarring can cause depigmentation. In
leukoderma, newly formed skin may not have acquired a melanocyte
population, resulting in white skin appearance. In albinism there are normal
melanocytes, which are prevented from forming melanin pigment because of
an enzymatic defect.
3.2 HYPERKERATOSIS
A number of conditions are associated with excessive surface keratin layers.
If keratin is wet, it becomes opaque and appears white in colour. The thicker
the keratin, the whiter the skin appears. For this reason, hyperkeratotic
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vulva! skin, which is in an area of constant moisture, appears typically white
in colour.
The end result of chronic infection may be scarring and thickening of the
skin with white change. Benign tumours such as papillomatous or verrucous
lesions may demonstrate areas of hyperkeratosis and white change. Skin can
also appear pale when superficial blood vessels are constricted, when
interposing distance between them and the surface is increased, or when they
are numerically decreased by a sclerotic process. All three of these
mechanisms are indeed active in the white skin lesions seen in the vulva!
dermatoses.
4. VULVAL DERMATOSES
4.1 CLINICAL FEATURES OF VULVAL DERMATOSES/NNEVD
4.1.1 LICHEN SCLEROSUS
Lichen sclerosus typically occurs in childhood, regress following the
menarche and recurs after the menopause. [121 The skin in affected areas
appears white, crinkled, scaly and thin. [Photograph number 1, page 72] It
usually affects the skin of the labia majora, minora, clitoris as well as perianal
area with relative sparing of the area in-between. This produces the typical
"figure of 8" appearance which is classical, but not pathognomonic of lichen
15
sclerosus. 1391 In untreated patients there is obliteration of the clitoris by
oedema with phimosis and atrophy and shrinkage of the labia minora and
introitus. This commonly produces the symptom of dyspareunia or painful
coitus. 191
In the early stages of the disease, the labia minora may fuse with the labia
majora and disappear completely as a result of atrophy. The skin may split in
the midline especially between the clitoris and urethra. In the natural folds of
the skin, fissures may develop. This may also occur in the posterior portion
of the fourchette. The white plaques may become confluent and guttate; in
which case it may resemble that of scleroderma, with which it is significantly
associated. 1311 Both these conditions can become bullous, especially
scleroderma resulting in confusion in making a diagnosis.
Up to 20% of patients with lichen sclerosus have extragenital lesions, which
present as small ivory, shiny macules or papules, that become atrophic and
are usually asymptomatic. " 13 Extragenital lesions may occur on any part of
the trunk, upper and lower limbs. A common area is the anterior aspect of
the wrists. The Koebner phenomenon often occurs. The Koebner
phenomenon refers to the occurrence of lichen sclerosus at sites of trauma,
when the lesion is also present elsewhere on the body. Lichen sclerosus has
been noted to occur at the site of radiotherapy for carcinoma of the breasts
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in two patients who had no lesions elsewhere. [401 The existence of oral lichen
sclerosus is disputable and histological confirmation is rarely present.
Vesicles and bullae, sometimes haemorrhagic, may occur. Small
telangiectases and purpuric lesions sometimes occur probably as a result of
injury to the atrophic skin. The disorder is much less common in children
than in adults. Published series show from 2% 14 " to 1 5% 1421 of cases begins
before the age of 1 3. The earliest reported age of onset was 6 months. [431
In Wallace's series [311 [1971], 28 of 50 started between the ages of 3 and
6 years. The clinical features of childhood lichen sclerosus are the same as
that in adults. [441
The general health remains normal and often the condition is asymptomic. A
vaginal discharge may precede the vulval lesions in about 20% of patients.
However, the commonest presenting symptom is that of pruritus vulvae
which may occur in up to 60-70% of patients. It seems that the more
hyperplastic the lesion, the more severe is the pruritic symptom.
PROGNOSIS OF LICHEN SCLEROSUS
Whilst it is generally agreed that extragenital lesions of lichen sclerosus




 et al [1971] noted that in two thirds of patients with
anogenital lesions, the lesions cleared around the time of puberty. Detailed
follow-up is usually not available. In Wallace's report, the regression is mainly
of symptoms rather than signs. It seems therefore, that although the
condition looks and feels better around the time of puberty, proof that it
actually remits is lacking. The condition does not seem to remit in middle
age, except in the extragenital sites. Therefore, it may very well be that
lichen sclerosus does not remit at all. This is often supported by the fact that
adult patients often recollect symptoms of lichen sclerosus in childhood.
Adult women with lichen sclerosus may complain of dyspareunia, but
pregnancy appears to be uneventful. [191
4.1.2 Squamous Cell Hyperplasia
Squamous cell hyperplasia typically presents as thick white skin involving the
labia majora, outer aspect of the labia minora, interlabial sulci and perineum.
[Photograph number 2, page 73] In both lichen sclerosus and squamous
cell hyperplasia there is hyperkeratosis producing the white skin appearance.
In addition, in squamous cell hyperplasia, the rate of melanin production by
the melanocytes cannot keep pace with the rate of growth of epithelial cells.
Areas of squamous cell hyperplasia may be localized, elevated and well
defined. In some patients the lesions are poorly defined. The vulva is usually
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white in colour and due to the hyperplasia and hyperkeratosis, the skin is
thick in texture.
In black patients the appearance may be dramatic and is often confused with
vitiligo. However, in vitiligo the skin usually has a smooth surface. There
may be fissures and excoriation, the result of chronic scratching. Many
patients present with pruritus vulvae although some may present with
soreness, burning and vulva! pain [vulvodynia]. [71 Most patients are younger
than 50 years of age, although it may occur in the older patients. In a small
percentage of patients, the lesions may be detected at routine gynaecological
examination. There are an even smaller percentage of patients whose
presenting complaint is one of a white vulva! skin lesion.
4.1.3 OTHER DERMATOSES
4.1.3.1 LICHEN SIMPLEX CHRONICUS
Lichen simplex chronicus presents as thick, leathery white skin, which
affects the labia. It is thought to be a secondary dermatoses, following
chronic rubbing or scratching of the skin. Chronic contact or irritant
reactions can provoke scratching as can any infection. The provoking
stimulus may resolve, but lichen simplex chronicus persists because the
patient continues to irritate the involved area. The affected skin becomes
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lichenified, thickened and leathery with prominence of normal skin
markings. [Figure 1, page 74] Pruritus is always a major symptom and
with time, it may become impossible to tell whether the patients'
scratching has triggered the itch or vice versa. Lichen simplex chronicus
seems to develop more easily in-patients with atopic eczema. [4°1 The
lesions may be confined to the vulva or may be part of general
dermatoses with the antecubital and popliteal fossae being the
commonest extragenital sites involved. [451
4.1.3.2 LICHEN PLANUS
Lichen planus is typically a pruritic eruption of shiny, smooth, flat-topped
papules on the skin and white patches or erosions on the mucous
membranes. [Figure 2, page 75] The papules are usually purplish-white
in colour forming a lacy pattern. Patients first notice lesions on the lips
and the gynaecologist may be the first to find asymptomatic vulva!
lesions. Almost two thirds of patients with lichen planus have mucous
membrane involvement [391 and some have disease limited to either the
genitalia or oral mucosae.
The lesions typically occur on the anterior aspect of the wrist, lumbar
area of the back, medial thighs, ankles and shins. In the acute
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widespread variety, lesions begin on the extremities and spread rapidly
centrally to involve the trunk, sparing the face. Another type of lichen
planus lesion is that described as the erosive lichen planus which may
involve the vagina causing extensive desquamation of the vaginal mucosa,
with resultant synechiae formationP 1 A grey pseudomembrane is usually
noted. The vestibule may be erythematous and friable with an adherent
exudate. There may be marked resorption of the labia minora. Atrophy
may occur including obliteration of the clitoral head. Patients sometimes
complain of pruritus, burning, dysparenia and the feeling of "rawness".
The onset of the erosive type of lichen planus may preceed or follows
vulvovaginal lesions many months later.
4.2 HISTOPATHOLOGICAL FEATURES OF THE VULVAL DERMATOSES
4.2.1 LICHEN SCLEROSUS
The histological features of lichen sclerosus are usually typical. 
139]
 There is
hyperkeratosis or thickening of the keratin layer producing the white skin
lesions. The epidermis is markedly thinned with flat rete pegs. There is
cytoplasmic vacuolization of basal cells and follicular plugging. Beneath the
epidermis there is a characteristic zone of homogeneous, pink-staining,
collagenous-appearing tissue which appears acellular. Oedema is usually
noted in these areas. Immediately below this area, in the mid-dermal zone,
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lies a band of chronic inflammatory cells made up mainly of plasma cells and
lymphocytes. There may be areas of hyperplastic squamous epithelium
present, which usually occurs secondary to chronic scratching of the vulva!
skin. [Photograph number 3, page 76]
4.2.2 SQUAMOUS CELL HYPERPLASIA
The histological features consist of a variable increase in thickness of the
keratin layer [Hyperkeratosis] and irregular thickening of the malpigian layers
[Acanthosis]. Acanthosis results in epithelial thickening associated with
lengthening and distortion of the rete pegs into either clubbed or pointed
structures. The granular layer is sometimes prominent. Due to the
elongation of the rete pegs, the papillae become conspicuous and
oedematous. A chronic inflammatory cell infiltrate consisting of plasma cells
and lymphocytes is often present within the dermis. [Photograph number 4,
page 77] Squamous cell hyperplasia is usually a diagnosis of exclusion when
the acanthosis cannot be attributed to a specific dermatosis, or a pathological
process that would explain the hyperplastic process. [461
4.2.3 Lichen Simplex Chronicus
In well-developed cases of lichen simplex chronicus, there is hyperkeratosis,
acanthosis, and elongation of the rete pegs, fibrosis of the papillary dermis
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and a mild inflammatory infiltrate. [Photograph number 5,page 78] There
is also an underlying dermatosis seen which results in epithelial thickening.
[36]
4.2.4 LICHEN PLANUS
The histological features of lichen planus of the vulva are similar to that
found elsewhere in the body. These features include hyperkeratosis,
acanthosis, a dense subepithelial band — like infiltrate composed mainly of T-
Lymphocytes, which extends up to the basal layer where there may be
liquefaction, degeneration and the formation of colloid bodies. The rete pegs
are elongated and pointed. These histological features are as a rule, definite
and may be necessary if there are pale isolated papules similar to that of
lichen scierosus.
4.3 AETIOLOGY OF VULVAL DERMATOSES
The aetiology of the vulval dermatoses remains obscure although various
theories have been suggested, viz.:
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4.3.1 LINK WITH AUTOIMMUNE DISEASES
An association of lichen sclerosus with autoimmune diseases has been
suggested. Wallace 1311 et al [1971] suspected a significant association with
vitiligo. Meyrick-Thomas' 471 et al [1983] studied the relationship between
autoimmune diseases, autoantibodies and lichen sclerosus in 25 men. They
found a significantly higher frequency of autoimmune related disorders
compared to a control population. There was also a higher frequency of
autoantibodies than expected in a normal male population.
Ridley et al [391, later confirmed these findings in a study of more than 200
patients. A later study by Meyrick-ThomasE 481 et al [1988] found
autoimmune related disorders in 59.5% of patients studied. Of the 350
women studied, 21.5% had one or more autoimmune related disease, 21 %
had one or more first degree relatives with autoimmune related disease,
42% had an autoantibody titre greater than 1 in 20 and almost 60% had
one or more autoimmune related phenomenon, i.e. a personal or a family
history of an autoimmune related disease including allopecia, vitiligo,
thyrotoxicosis, hypothyroidism, pernicious anaemia, diabetes mellitus,
systemic lupus erythematosus and primary binary cirrhosis. The conditions
most often linked in affected women are thyroid disease and allopecia.
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Goolamali 1491 et al [1974] reported a link between patients with vitiligo and
lichen sclerosus. In twenty-six patients with lichen sclerosus, it was found
that 40% had anti-thyroid antibodies and 44% had antibodies against gastric
parietal cell. It was therefore felt there could be a link between lichen
sclerosus and an autoimmune process. It has been noted that there is a
relationship between patients with Sjogren's syndrome and vulva!
dermatoses. Thus, it is postulated that there may be a relationship between
autoimmunity and vulva! dermatoses.
Achlorhydria has been noted to be present in some cases of vulval
dermatoses of which many were probably lichen sclerosus. leffcoatel'l et al
[1966] noted this to be the case in 23% of 269 patients with vulva!
dermatoses. Lavery1511 et al [1984] found achlorhydria in 10 of 18
patients with "chronic vulval dystrophy" and speculated, about a relationship
between the effect of urogastrone [epidermal growth factor] on the skin and
on gastric acidity and the opposing effect of somastatin. Johansson [521 et al
[1986] noted immunoreactivity to a substance like vasoactive intestinal
peptide in cells of the epidermis in two out of four patients with lichen
sclerosus and cells of the epidermis to substance like vasoactive intestinal
polypeptide.
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In contrast, Harrington and Dunsmore [531 et al [1981] noted a low
occurrence of autoimmune phenomena and lichen sclerosus, especially with
regards the natural history. This was further supported by the failure to
demonstrate an association between lichen sclerosus and HLA-B 8 or DRw3,
the tissue types found to have an increased prevalence in individuals with
diseases considered to have autoimmune basis.
Meyrick-ThomasE
481
 et al [1988] further noted no relationship between
autoimmune phenomenon and the natural history of lichen sclerosus [sites of
involvement, age of onset, onset in relation to menarche and menopause or
the development of malignancy] of those with or without antibodies.
Harringtoni"I et al [1984] found a non-statistically significant increased
incidence of HLA-B40 in 50 women with lichen sclerosus. Meyrick-
Thomas [551 et al [1984] also found a non-statistically significant association
with HLA types in 92 women and 28 men with lichen sclerosus.
4.3.2 Hormone Dependency
It is well recognized that when lichen sclerosus occurs in pre-pubertal girls
there is often resolution when puberty is reached. "" 1 This would suggest that
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lichen sclerosus may be influenced by oestrogen, but the use of topical
oestrogens have been disappointing. Cinberg 1561 et al [1945] noted an
improvement in vulva! lichen sclerosus following the application of topical
testosterone and others have investigated this further. Friedrich and Kalra' 571
et al [1984] studied 30 patients with untreated lichen sclerosus and found
reduced serum levels of dihydrotestosterone and androstenedione and
significantly increased levels of free testosterone. When patients were treated
there were significant increases in total testosterone and dihydrotestosterone
levels than in a control group.
These findings provide the basis for the treatment of lichen sclerosus with
testosterone cream. It is hoped that, by inundating the skin with substrate,
some of it will undergo conversion, thereby exposing the tissues to the
deficient hormone.
These authors suggested that there may be a block in converting testosterone
to dihydrotestosterone and postulated a reduction in 5 alpha reductase
activity. However, in females with documented reduction in 5 alpha
reductase activity, there has not been shown to be any increase incidence of
lichen sclerosus. Other authors [581 have looked at hormone receptor levels
and have found that there is elevated levels of progesterone receptors. This
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could explain the beneficial effects of progesterone therapy for lichen
sclerosus.
4.3.3. INFECTIVE LINK
There have been suggestions that lichen sclerosus may be due to a
spirochetal infection: [591 There is similarity in the skin lesions of scleroderma
and Lyme disease. Lyme disease is caused by the spirochete Borrelia
burgdoferi. There is similarity in the skin lesions of scleroderma and lichen
sclerosus. 16°1 However, these spirochetes as well as anti-Borrelia antibodies
have not been found in lichen sclerosus. This link has not been confirmed.
Karram 1611 et al [1988] studied the relationship between the vulva!
dystrophies and the presence of the human papilloma virus. There were no
associations noted between the non-atypical dystrophies and the human
papilloma virus.
4.3.4 MISCELLANEOUS CAUSES
There may be yet, other unknown causes, which may play a role in the
vulva! dermatoses. Barnes 
[621
 et al [1985] noted an increase in collagen
inhibitor enzyme and an absence of collagenase in lichen sclerosus compared
with the normal vulva! tissue and that from other vulva! conditions. The




 et al [1980] and Carli [651 et at [1991] suggested that the skin's
immune system might play a role in the pathogenesis of lichen sclerosus.
They observed an increase in activated T lymphocytes in the dermis as well
as persistent increase in the number of epidermal Langerhan's cells in lichen
sclerosus.
The concept of familial predisposition to the development of lichen sclerosus
is well supported by reports of Wallace ['let al [1971], Friedrich [641 et al
[1984] and Barker ['
]
et al [1962]. Murphy (681 et al [1982] noted lichen
sclerosus to be present in three sisters, one of whom had pernicious anaemia
and vitiligo. Meyrick-Thomas 
[69]
 et al [1986] reported the presence of
vulva! lichen sclerosus in identical twins.
It is felt that although the environment of the vulva influences the various
pathologic processes, the role of chronic trauma, allergy, nutritional
deficiency, psychoneurosis, metabolic disturbances and other factors are
unknown. There seems to be a likely relationship of chronic vulvovaginal
infections like candidiasis to lichen simplex chronicus, especially in-patients
with diabetes mellitus. [391
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The role of race or ethnicity is not clear, although, it appears to be
commoner in Caucasian females. [191 Barclay [701 et al1966][ and Dogliotti
[711 et al [1974] described lichen sclerosus in Black patients.
4.4 RELATIONSHIP BETWEEN VULVAL DERMATOSES AND VULVAL
MALIGNANCY
Lichen sclerosus at extragenital sites seems to have no risk of progression to
malignant change. 
[191
 Basal cell carcinoma has been noted to occur in-
patients with lichen sclerosus. [72,731 1t is unclear if this association is
fortuitous or not. Freidman [741 et al [1984] noted the association of
malignant melanoma with lichen sclerosus on the vulva of a 14-year-old.
One area of debate has been the risk of progression of the vulva! dermatoses
to invasive squamous cell carcinoma of the vulva.
McAdams [721 et al [1958] found lichen sclerosus to be present in 16 out of
400 cases [4%] and leukoplakia, presumably lichen sclerosus in 31 patients
[12%],with vulva! carcinoma. Buscema 1' 1 et al [1980] studied 98
patients of squamous cell carcinoma and found "dystrophies" in 49 patients.
Zaino 
[761
 et al [1982] examined squamous cell carcinoma in 60 patients
whom had vulvectomy. It was found that 32 patients had "Atypical
Hyperplastic Dystrophy," 15 lichen sclerosus, 14 hyperplastic dystrophy and
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19 carcinoma in situ. Hewitt [771 et al [1976] found lichen sclerosus to be
present in 96% of 104 women with squamous cell carcinoma.
Very few prospective studies have been done with regards to the risk of
progression of the vulval dermatoses to invasive squamous cell carcinoma of
the vulva. 
[22, 50, 72] 
It was noted that cancer rarely develops subsequently in
women under close clinical supervision for chronic vulval diseases. Jeffcoate
150] et al [1976] noted that the risk of developing invasive carcinoma of the
vulva in-patients with chronic vulval dystrophy in 138 women studied,
ranged from 3-5% over a period of 3-25 years. Walkden [781 et al [1993]
found the incidence of progression to be close to 9%.
Buckley [791 et al [1984] found that vulval intraepithelial neoplasia and
lichen sclerosus may co-exist and this could increase the number of
malignancies found with lichen sclerosus. Leibowitch [801 et al [1990] noted
lichen sclerosus in 61 % of women with vulval carcinoma. Fifty percent of
these women had associated well-differentiated vulval intraepithelial neoplasia
grade III. It was further observed that the undifferentiated form of vulval
intraepithelial neoplasia grade III was not associated with lichen sclerosus. In
those patients with carcinoma associated with lichen sclerosus, there was no
evidence of the human papillomavirus [HPV/ DNA]. However, HPV/ DNA
was found in association with severe vulval intraepithelial neoplasia.
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In contrast, it was found that HPV type 16/18 was present in invasive
squamous cell carcinoma in patients with lichen sclerosus.
In summary, the risk of vulva! squamous carcinoma developing in a patient
with vulva! dermatoses is in the order of 1- 5% over a prolonged period of
time. The risk factors for the progression of the vulval dermatoses to invasive
carcinoma include a history of lichen sclerosus in childhood, co-existence of
HPV 16/18 and the erosive type of lichen planus. 1391
5. VULVAL INTRAEPITHELIAL NEOPLASIA [VIN]
5.1 EPIDEMIOLOGY OF VULVAL INTRAEPITHELIAL NEOPLASIA
During the past 20 years there has been an increase in the reported
incidence of vulva! intraepithelial neoplasia, especially in premenopausal,
sexually active women. 1811 Knight [821 et al [1973] reported 26 cases of
carcinoma in situ of the vulva while Woodruff 183] et al [1943] reported on
44 cases diagnosed between 1966 and 1972. Sturgeon [841 et al [1992]
noted that the incidence rate of VIN III had nearly doubled between 1973
and 1976 and 1985 to 1987. During the same period, however, the
incidence rate for invasive carcinoma of the vulva remained stable. They also
found that the incidence of VIN III increased from 1.1 to 2.1 cases per 100
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000 women/year. The largest increase occurred in white women less than
35 years of age.
In the past the mean age of presentation of VIN was 50 years. 
[85]
 However,
today the commonest age of presentation ranges between 28 — 35 years.
[81,86] This could be due to the fact that there is heightened awareness of
neoplasia and increased tendency to take a biopsy as well as the frequent
occurrence of viral infections of the lower genital tract.
There is no particular racial predisposition, with Whites and Blacks being
equally affected. Whilst there is no relationship between the NNEVD and
sexually transmitted diseases, there is a strong relationship between VIN and
sexually transmitted diseases. [811 The most common pathogens implicated
include Human papillomavirus, Treponema pallidium, Trichomonas vaginalis,
Gardnerella vaginalis etc. There is a common association with
immunosuppressed states 
[87,88]
 viz. renal transplants, systemic lupus
erythematosus, cytotoxic agents etc.
5.2 VIN AS A MULTICENTRIC DISEASE
Vulva! intraepithelial neoplasia is commonly associated with cervical
intraepithelial neoplasia in 11 — 80% [89,94] of patients as well as with
intraepithelial neoplasia of other genital tissues, including the anal canal. All
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these intraepithelial neoplastic lesions are well-documented precursors of
invasive squamous carcinoma in these areas. It is thought that a common
oncogene affects the lower female genital tract, with the vulva and cervix
being the most susceptible sites. When VIN is diagnosed, the chance of
finding a concurrent cervical intraepithelial neoplastic lesion ranges from 11
— 80%.
5.3  NOMENCLATURE OF VIN LESIONS 
In 1984 and again in 1987, the nomenclature committee of the
International Society For The Study Of Vulva! Diseases [391 proposed a
classification for intraepithelial neoplasia involving the vulva. They grouped
the diseases of squamous cell type under a single heading. On the other
hand, Paget's disease and melanoma in situ, having distinctly different
histopathological appearances, histochemical characteristics and natural
histories, were subclassified. The classification of VIN lesions depend on the
level in the epithelium the dysplastic cells are found and is as follows;
A. Squamous: VIN — I [Dysplasia — mild]
VIN — II [Dysplasia — moderate]
VIN — Ill [Dysplasia — severe, carcinoma in situ]
B. Other: Paget's disease [Intraepithelial]
Melanoma in situ [Level 1]
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5.4 CLINICAL FEATURES OF VULVAL INTRAEPITHELIAL NEOPLASIA
Vulva! intraepithelial neoplastic lesions commonly present as white skin
lesions of the vulva, because of the hyperkeratosis. The lesions may be
asymptomatic and discovered at routine gynaecological examination, or
present more commonly as pruritus vulvae. 190I The diagnosis is confirmed by
histological examination.[Figure 3, page 79]
5.4 HISTOPATHOLOGICAL FEATURES OF VULVAL INTRAEPITHELIAL
NEOPLASIA
The histological features of VIN are classified according to whether the
cellular abnormalities and lack of stratification are limited to the lower third
of the squamous epithelium [VIN 1], middle third [VIN 11] or upper third of
the epithelium[VIN 111].[Photograph number 6, page 80] In the basaloid
form of VIN, a parakeratotic layer overlies an epithelium containing closely
packed, non-stratified cells which show nuclear crowding and a high
nucleocytoplasmic ratio. In the Bowenoid form of VIN, there may be
hyperkeratosis, premature cellular maturation, variable retention of
stratification and pleomorphism and koilocytosis. Both the basaloid and the
Bowenoid types may extend into the pilosebaceous units and sweat ducts. All
these changes are confined to the squamous epithelium of the vulva.
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5.5 COLPOSCOPIC FEATURES OF VIN 
Andreasson [901 et al [1985] and Buckley 
[791
 et at [1984] described the
colposcopic findings of VIN lesions. These include abnormal vascular
patterns with punctations, mosaicism or vascular irregularities present in up
to 60% of patients. The epithelial changes include the presence and degree
of acetowhitening of the epithelium following the application of 3% acetic
acid. The colposcopic findings may be limited by the presence of thick
keratin layers or congestion following infection or scratching.
5.6 PROGNOSIS OF VIN LESIONS
The risk of VIN grades I/II developing into invasive carcinoma is not clear,
although, Friedrich [911 et at [1981] regarded the risk to be low. It is
generally felt that the behaviour of VIN III is not comparable to that of CIN
III. Freidrich [911 et at [1981] reported only 4 of 106 patients [4%] with
VIN III to have developed invasive disease. Andreasson 
[901
 et at [1985]
quoted a figure of 2% risk of progression of severe grade VIN . Most
reported cases where VIN had progressed to invasive carcinoma have
occurred where the patient was old or immunosuppressed. [87,881
Friedrich 
[911
 et al [1981] and Bernstein 
[92]
 et at [1983] found that even
untreated cases of aneuploid VIN III may undergo spontaneous regression.
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Data on progression rates may be biased since majority of patients with VIN
have been subjected to multiple treatments or diagnostic excisional biopsies.
Bergeron [93] et al [1987] noted that untreated long standing, histologically
verified VIN has high progression rates in the order of 90 — 100%.
Progression transit times range from 2 — 10 years. The human
papillomavirus type 16 in association with VIN has been frequently noted to
progress to invasive disease as compared to HPV types 6/11.
6. PAGET'S DISEASE OF THE VULVA
Extramammary Paget's disease is a slowly growing intraepithelial carcinoma
containing vacuolated Paget's cells. Of significance is that Paget's disease may
be associated with an underlying carcinoma of the apocrine structures of the
vulva, e.g. Bartholin's gland as well as anorectal carcinoma, breast carcinoma
and squamous cell carcinoma of the vulva, vagina and cervix. [941
6.1 CLINICAL FEATURES OF PAGET'S DISEASE
Paget's disease of the vulva generally affects Caucasian women in the
postmenopausal age group, with the mean age of diagnosis being 65 years.
The clinical presentation may be striking, with white epithelium scattered
over a bright red base.[Figure 4, page 81] As a rule, the disease begins on
the hair-bearing parts of the vulva, genital folds or perianal region, but may
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extend to involve the labia minora and introital structures. Less frequently,
Paget's cells may spread into the mucosa of the urethra, urinary bladder,
ureters and even endocervix. 1951 The commonest presenting symptoms are
pruritus vulvae, soreness and burning. 1963
6.2 HISTOLOGICAL FEATURES OF PAGET'S DISEASE
The histological features of Paget's disease are quite typical.[Photograph
number 7, page 82] The characteristic cell is the Paget cell which are large
irregular cells containing clear vacuolated cytoplasm. The nuclei are vesicular
and vary in size and shape. These cells may be isolated or occur in clusters at
the tips or adjacent to the rete pegs deep in the epithelium. Paget's cells can
be found in the epidermis well beyond grossly visible normal surgical
margins. 
[39]
 Histochemical staining confirms the diagnosis of Paget's disease
and exclude melanoma or squamous cell carcinoma in situ.
7. INVASIVE CARCINOMA OF THE VULVA
Vulva! carcinoma is rare, representing only 3 —5% of genital cancers. Green
[97] et al [1978] found there is an increase in incidence to about 8% in
recent years. Vulva! cancer is mainly a disease of the aged, with the average
age being the seventh decade. However, it has been documented in girls in
their teens as well as in women in their 20's and 30's. No definite cause has
been identified with regards the aetiology of vulval cancers. However, certain
3 8
risk factors have been identified such as a long standing history of VIN, viral
agents such as human papillomavirus types 16/18, vulva! condylomata and
immunodefficiency states. [98, 99]
7.1 CLINICAL FEATURES OF INVASIVE CARCINOMA OF THE VULVA
Up to 75% of patients may present with a mass lesion of the vulva.[Figure
5, page 83] Between 27 — 71% of patients complain of pruritus vulvae and
6 — 41 % have a discharge or present with bleeding. Some patients may also
complain of pain. Whilst the macroscopic features may be exophytic or
ulcerated, some patients may present with a white vulva! skin lesion. [19]
7.2 HISTOLOGICAL FEATURES OF INVASIVE VULVAL CARCINOMA
There are many variants of squamous carcinoma of the vulva. Well-
differentiated tumours usually have islands, anastomosing masses and
infiltrating cords of squamous cells. These cells show progressive nuclear and
cytoplasmic maturation and keratinization towards the center of these
masses. The underlying tissue usually has plasma cells and lymphocytes in
varying amounts.[Photograph number 8, page 84]
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CHAPTER TWO
1. MANAGEMENT OF WHITE VULVAL SKIN LESIONS 
1.1 INVESTIGATIONS 
There have been various modalities of therapy proposed for the treatment of
white vulval skin lesions. These include medical and surgical approaches. An
area of uncertainty has been the approach to management of a patient with a
white vulva! skin lesion. There has been a tendency to treat these patients
without any investigations. However, since the causes of a white vulva! skin
lesion are variable ranging from benign to malignant causes, many authors
[11,12,13,14] advocate an approach which includes doing a Pap smear,
colposcopy of the vulva [vulvoscopy], vagina and cervix, Collin's test
[toludine blue test] and biopsy of abnormal areas to establish the cause. This
would guide clinical management as well as exclude the presence of
underlying premalignant or malignant conditions.
1.1.1 ROLE OF COLPOSCOPY OF THE VULVA AND ADJACENT SITES
1.1.1.1 BACKGROUND
The colposcope [Photograph number 9, page 85] was introduced to
evaluate abnormal cervical cytology since it has been shown to be
reliable in predicting histological alterations. I'l Several studies
[101,102,103] assessing various therapeutic agents in the treatment of the
vulva! dermatoses have used vulvoscopy in their methods. Vulvoscopy
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is also used now to evaluate vulval complaints and pathology, [104,105]
for diagnostic workup in women with abnormal pap smears 
[106] 
and
to remove all vulvoscopically visible VIN HI lesions. 
[107,108] 
The main
aim is to select abnormal sites to biopsy in order to exclude
malignancy. [109 The predictive value of vulvoscopy has been
regarded to be uncertain mainly because normal vulvoscopic findings
had not been determined in women without vulva! complaints. It was
therefore difficult to distinguish normal from abnormal findings.
1.1.1.2 NORMAL VULVOSCOPIC FINDINGS
Recently Van Beurden 
[13]
 et al [1997] and Apgar " 101 et al [1996]
have described normal vulvoscopic findings. It has been shown that
vestibular erythema, vestibular papillomatosis and acetowhite lesions
[30%] are common in healthy sexually active women without vulva!
complaints. It is thought that vestibular papillomatosis is probably
congenital in origin and could be accentuated by any inflammatory
condition. These micropapillae have been found to lack HPV DNA
on hybridization studies.
A "cobblestone" appearance at the inferior part of the vestibule is
thought to represent sebaceous hyperplasia, which occurs secondary
to age or inflammation, producing hypertrophy of these glands. Non
— specific acetowhite areas have been described at the junction of the
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inferior part of the vestibule with the perineum. These changes are
not due to the human papillomavirus infection but are thought to
occur secondary to the trauma of intercourse, yeast infections or any
other inflammatory conditions of the vulva. This type of
acetowhitening is usually diffuse and flat, whereas that due to HPV
infection is slightly raised with satellite lesions. Acetowhite lesions
without vascular abnormalities are common on the vulva. Therefore
not every acetowhite area contains dysplastic cells.
1.1.1.3 LIMITATIONS OF VULVOSCOPY
There are 3 limitations to colposcopy of the vulva and perineum.
These include hyperkeratosis preventing underlying vascular and
epithelial abnormalities being visible, light reflection from keratin and
the presence of hair — bearing skin at the site of the lesion. To
overcome these problems, it has been recommended that hair be
clipped at the site of the lesion and KY Jelly be applied on the skin to
reduce the light reflection from the keratin. [1111 KY Jelly is a non-
toxic water-soluble agent, which does not interfere with other
substances used during colposcopic examination.
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1.1.1.4 TECHNIQUE OF VULVOSCOPY
Colposcopy is done using the technique described by Hatch 
[112] 
et al
[1993]. A colposcope with multiple magnification settings is
necessary to facilitate the examination. The patient is placed in the
lithotomy or dorsal position. The tissue to be examined is cleaned
with saline, and then 3% acetic acid is applied. After 2 — 3 minutes
the skin is examined under the colposcope for epithelial and vascular
abnormalities. All abnormal areas are biopsied.
1.1.2 COLLIN'S TEST [ TOLUDINE BLUE TEST] 
1.1.2.1 BACKGROUND 
The Collin's test was first used by Richart 
1113]
 et al [1963] and later
modified by Collin's [ I 41 [1966], for vulva! conditions as a diagnostic
aid to delineate suspicious skin for biopsy. Toludine blue is a nuclear
stain and when applied to tissues in vivo, becomes fixed to cell
nuclei. Dilute acetic acid decolourizes any dye, which is not bound to
nuclear material. In normal skin, keratin has no nuclei and therefore
the dye is usually washed away with acetic acid.
Whenever there is a break in continuity of the epidermis, as occurs
with an ulcer, or if nucleated squames are present in the upper
epithelial layers, the skin would retain the dye. This would occur if
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there are premalignant or malignant cells with nuclear material
present in the upper epidermis.
1.1.2.2 LIMITATIONS OF COLLIN'S TEST
Reid 
[111] 
et al [1995] and Cavanagh [161 et al [1985] considered this
test to be useful although, limited by false negatives associated with
hyperkeratosis and false positives due to excoriation. Thus, areas,
which are ulcerated or excoriated, as is often the case in patients with
pruritus vulvae, would stain positive.
Freidrich °n et al [1983] disregarded the false positive results and
felt that much of the disappointment expressed with regards this test
stemmed from the lack of understanding of its basic method of
action. Many clinicians regard this test as a test for cancer, when in
fact it is a simple test to indicate the presence of superficial nuclei.
The presence or absence of cancer can only be confirmed by biopsy
and histological assessment.
1.1.2.3 TECHNIQUE OF COLLIN'S TEST
The skin to be examined is first cleaned with saline or acetic acid.
Toludine blue aqueous solution [1%] is then applied to the skin with
a cotton swab and allowed to dry for one minute. The entire vulva is
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then rinsed gently with 1-°/0 aqueous acetic acid solution. Abnormal
epithelium, if present, will stain royal blue.
The main argument for these investigations is to obtain directed
biopsies rather than doing random biopsies, [14,114] which could miss
representative areas. This needs to be appreciated, as the abnormal
areas can be quite large, making it difficult to select sites for biopsy.
Another significant fact is that some of the lesions tend to be
multicentric, therefore, colposcopy of these areas is necessary to
determine the extent of the underlying disease process.
1.1.3 VULVAL BIOPSY
All abnormal areas detected by colposcopy and Collin's test need to be
biopsied for diagnosis and treatment. Vulva! biopsy is a minor procedure
which does not require general anaesthetic and can be done as an out —
patient procedure. Anaesthesia can be accomplished by the local infiltration
of 1 0/0 lignocaine injected subcutaneously using a dental syringe. Biopsies can
be taken using a special vulva! skin biopsy instrument such as a Keyes biopsy
punch [Figure 6, page 86] or cervical biopsy instrument or using a scalpel
blade. The Keyes cutaneous instrument [171 is used to core out a small
circular plug of skin. It is obtainable in diameters ranging from 2 — 12
millimeters. The instrument is pressed against the skin, turned clockwise and
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then anti-clockwise. A core of tissue is obtained containing epidermis and
dermis. Alternatively, biopsy specimens can be obtained using a scalpel with
a number 1 1 blade. An elliptical incision is made and the tissue removed.
Minor bleeding can be stopped using a silver nitrate stick or a drop of
Monsel's solution. Large defects or significant bleeding is treated by inserting
3 — 0 chromic sutures. These biopsy sites usually heal within 2-3 weeks. Post
biopsy discomfort is usually minimal and simple analgesia usually suffice.
Specimens are sent in formalin solution to the laboratory for
histopathological assessment.
2. THERAPEUTIC STRATEGIES: WHITE VULVAL SKIN LESIONS 
Depending on the aetiology, there have various modalities of treatment
proposed for the management of white vulva! skin lesions. These modalities of
treatment usually range from medical to surgical.
2.1 VULVAL DERMATOSES
Generally, a search should be made for any possible aggravating factors such
as Trichomoniasis, Candidiasis and allergy to various agents. If any of these
are present the patient should be treated appropriately.
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2.1.1 LICHEN SCLEROSUS 
Since lichen scierosus has atrophic histological features, treatment has
generally consisted of using androgenic steroids such as topical Testosterone
preparations. [1061 Androgenic steroids are trophic hormones and are
therefore appropriate in these conditions.
2.1.1.1 CHILDHOOD LICHEN SCLEROSUS 
Lichen sclerosus in childhood, which is usually asymptomatic usually,
does not require any treatment, except patient reassurance and follow
up. The aim of treating childhood lichen scierosus is to relieve the
pruritus. The recommended initial treatment consists of topical 1%
Hydrocortisone cream, alternating with bland emolient cream. 
[431
 If
there is no response to topical 1% hydrocortisone cream, then
Progesterone ointment [compounded as 100 mg of progesterone in 1
ounce of petroleum] may be effective. Topical testosterone should
not be prescribed for prepubertal females because of the risk of
masculinising side effects. 
[451
 Most children who respond to topical
methods remain asymptomatic, although, careful follow up is
necessary to exclude the development of malignancy in later life.
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2.1.1.2 ADULT LICHEN SCLEROSUS 
Various steroid preparations have been used for the treatment of
adult lichen sclerosus. Initially 1 % topical hydrocortisone cream
should be applied. In most cases this is all that may be needed for the
relief of pruritic symptoms. " 151 Testosterone propionate in sesame
oil, 100 mg/ml is mixed in petroleum base to obtain a 2% ointment.
This medication is applied 2-3 times daily for 3-6 months or until the
pruritus has subsided. Therefore the frequency can be reduced over 1
to 2 years when it may be used once or twice weekly. Generally,
testosterone and progesterone preparations for this purpose is not
available commercially and has to be compounded by the pharmacist
on request. Mahmud 11161 et al [1992] reported symptomatic
improvement and reduction in lesion size in 80% of patients with
lichen sclerosus treated with testosterone and corticosteroids.
One of the most effective agents reported for the treatment of vulval
lichen sclerosus is clobetasol propionate [0.05%] [ DERMOVATE,
Glaxo, UK.] Bracco "'net al [1993] in a randomized comparative
study compared the efficacy of topical testosterone, topical 2%
progesterone in petroleum base, topical 0.05% Clobetasol
propionate and a placebo. The symptoms, gross appearance and
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histology were scored and repeated after 3 months of treatment.
Only the clobetasol group improved significantly with regards relief of
symptoms and improvement of objective and histopathological
findings. Patients treated with clobetasol experienced no adverse
effects, which can occur with 2% topical testosterone preparation.
Clobetasol [0.05%] should be applied twice daily for one month,
once daily for two months and then twice weekly for an additional 3
months. Equally satisfactory results were reported by Dalziel [1181 et al
[1991].
Bornstein [ 'let al [1998] reported the results of topical
testosterone [2%], clobetasol dipropionate [0.05%] versus topical
testosterone propionate [2%] for the treatment of severe lichen
sclerosus and confirmed a 75% resolution of symptoms with the
clobetasol group. However, unlike the high success rates previously
reported over the past 40 years with the use of testosterone, this
study found a lower success rate of 20% in patients treated with
testosterone.
Occasionally vulval pruritus is so severe that it is not relieved by
topical drugs. Here, the subcutaneous injection of Triamcinolone
acetonide [0.1%] 5 mg is diluted in 2 ml of saline and injected
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subcutaneously. Satisfactory results have been recently reported with
the use of oral retinoids for vulva! lichen sclerosus. Bousema "'let al
[1994] studied the efficacy of Acitretin [20 — 30 mg/day] for 16
weeks in a randomized, double — blind, placebo controlled trial using
78 patients. They found a 64% response rate in the acitretin group
compared to 25% in the placebo group. The major drawback with
the use of retinoids are their teratogenic potential and side effects.
Young patients need effective contraception during therapy as well as
for up to 2 years following discontinuation of therapy, as it has been
shown that the drug can be stored in adipose tissue for up to 2 years
after discontinuation of therapy, due to its highly lipophilic nature.
Major side effects reported with these drugs include skin dryness, eye
irritation, allopecia, myalgia and pseudoporphyria.
Sonnendecker 
[6]
 et al [1993] and Larsen [120] et al [1993] reported
on the use of intralesional injection of interferon alpha 2b, when
vulval dystrophy occurs in association with human papillomavirus
infection. They noted the relief of chronic vulva! discomfort and
limited reversal of histological changes.
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The role of surgery in the treatment of vulva! lichen sclerosus is
limited, as it has been shown that the risk of progression to cancer is
very small. Also, lesions often reappear in transposed skin over the
excised areas. [11] Surgery is justified only if pre -malignant or
malignant lesions are found in association with the vulva! dermatoses.
2.1.2 TREATMENT OF SQUAMOUS CELL HYPERPLASIA
Hyperplastic lesions are best treated with topical corticosteroids. Various
agents are recommended including 1% or 2.5% hydrocortisone cream,
0.025% Flucinolone acetonide, and 0.01 % triamcinolone acetonide. There
is a risk of atrophy of the tissues by using potent topical steroids. Therefore,
once the pruritus has settled, the potent topical steroids should be
discontinued and replaced with mild topical hydrocortisone cream.
Various adjuvant agents have been used with topical steroids for the relief of
pruritus. Some of these agents include topical Crotamiton and Calamine
lotion as well as oral anti- histamines such as chlorpheniramine 4 mg given at
bedtime. 1111 For patients with recaltricant pruritus, local injection of absolute




Unfortunately, the course of vulva! lichen planus is prolonged with or
without treatment. Corticosteroids, systemic and topical, are recommended.
Also, intravaginal Betamethasone valerate is recommended for vaginal lichen
planus. If there is extensive desquamatative vulvovaginal lichen planus, a
short course of oral prednisone, up to 70 mg / day for 14 days may provide
relief.
2.1.4 LICHEN SIMPLEX CHRONICUS 
Lichen simplex chronicus responds to topical steroids. It is recommended
that initial therapy should consist of potent steroids such as flucinolone
acetonide used for 6 weeks to control the inflammatory response.
Thereafter, lower potency steroids like triamcinolone acetonide 0.1°/o should
be applied daily or twice daily for up to 2 months as response occurs.
Topical 1% hydrocortisone cream should be used as maintenance
therapy. 1391 In children mild topical steroids are recommended.
2.2 MANAGEMENT OF VULVAL INTRAEPITHELIAL NEOPLASIA
Since the early 1960's and 1970's, there has been a radical change in the
management of vulva! intraepithelial neoplastic lesions. The treatment has
become more conservative with the recognition that spontaneous regression
occurs, as well as the fact that progression to invasive disease may be less
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likely in younger females. In addition, there may be functional impairment,
cosmetic as well as psychosexual sequelae with more radical procedures.
Generally, treatment should be individualized according to the location,
severity and extent of lesions. The presence or absence of factors increasing
the risk of occult invasive carcinoma should be considered. Treatment
modalities range from medical to surgical methods. Medical treatment
includes topical 5% 5- Fluorouracil cream [911, photodynamic therapy using
dihaematoprotoporphyrin and dinitrochlorobenzene sensitization therapy.
The problems encountered with medical therapies include extensive tissue
sloughing, severe discomfort, delayed healing, variable response rates and
insufficient patient numbers to evaluate success.
Surgical therapy includes wide local excision, skinning vulvectomy, carbon
dioxide laser therapy and cryotherapy. Skinning vulvectomy [151 is reserved
for very extensive four quadrant lesions followed by the application of split
thickness skin grafts. [122] Wide local excision is recommended for localised
lesions provided a I centimetre clear margin of normal skin is excised. 11221
Excellent therapeutic and cosmetic results may be obtained with the carbon
dioxide laser treatment of hairy and non- — hairy skin to a depth of 2
millimetres and 1 millimetre, respectively. [123] Deeper vaporization would
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destroy subcutaneous fat, skin appendages, resulting in delayed and painful
healing, scarring, dyspareunia and allopecia.
Cryotherapy has not gained popularity mainly because it produces delayed
and painful healing and failures or recurrences are common. 1122, 81]
Generally the recurrence rates for the surgical methods are variable, ranging
from 10%, if the surgical margins are free of disease, to 50% if the surgical
margins have residual disease. [124]
2.3 MANAGEMENT OF PAGET'S DISEASE
There is a high incidence of associated carcinoma of the breast and genitalia
in a patient with Paget's disease of the vulva. Therefore a thorough search
for these tumours should be made as the treatment of these tumours takes
precedence over the treatment of vulva! Paget's'disease. If no associated
malignancies are found, then the recommended treatment of the lesion
consists of excision of the lesion down to subcutaneous fat, in order to
exclude underlying sweat gland carcinoma. Previously, excision of the lesion
with wide margins was recommended. [391 However, it has been found that
recurrence rates of 12% occurs irrespective of the extent of histological
involvement. 1911
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2.4 MANAGEMENT OF SQUAMOUS CELL CARCINOMA OF THE VULVA
It is recognized that early invasive squamous carcinoma of the vulva can
present as a white vulval skin lesion. If invasive disease is diagnosed then the
current surgical staging should be used. 
[1251
 Management should be
individualized according to the stage of the disease and the trend is to use
less radical surgery due to recurrence rates, psychosexual sequelae,
complications and the fact that invasive carcinoma is now being diagnosed
earlier in younger patients with smaller lesions. 
[126,127] 
The surgical
management consists of two main aspects. Firstly, surgery of the vulva!
primary lesion itself and secondly, management of the regional lymph nodes,
where applicable, as described by Helm [1261 et al [1992].
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CHAPTER 3: THE STUDY - AN AETIOLOGICAL STUDY OF WHITE
VULVAL SKIN LESIONS AMONGST PATIENTS ATTENDING THE
GYNAECOLOGICAL CLINIC AT RK KHAN HOSPITAL, DURBAN. 
1. INTRODUCTION AND AIM OF THE STUDY
White skin lesions may be confined to the vulva or may involve the vulva as
well as other parts of the body. These lesions may occur in all age groups but
some tend to occur in childhood, regress following the menarche and recur
after the menopause. The aetiology of white vulval skin lesions are classified
into benign and non—benign causes. Whilst it is recognized that benign causes
such as those which constitute the entity of vulval dermatoses [ Lichen
sclerosus, squamous cell hyperplasia and other dermatoses] commonly
manifest as white vulval skin lesions, vulva! intraepithelial neoplasia, Paget's
disease of the vulva and early invasive squamous carcinoma of the vulva can
also present as similar clinical entities.
The dilemma faced by the clinician who manages a patient with a white
vulval skin lesion is the exact cause in that particular patient. There is often
uncertainty as to whether one should observe the lesion, biopsy the lesion or
treat without biopsing the lesion. There is also a problem of knowing which
site to biopsy since these lesions tend to be uniformly white and diffuse.
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In contrast, some authors recommend a structured approach consisting of
doing a Pap smear, colposcopy of the vulva, vagina and cervix and adjacent
sites, where appropriate, Collin's test and a biopsy of all abnormal areas
detected by these tests. This may seem to be unnecessary to those who
believe that many such lesions are benign, and justify treatment without
workup or tissue diagnosis.
However, judging from the literature, it is evident that benign as well as
premalignant and malignant conditions can present as white vulva! skin
lesions. It is also recognized that benign disorders such as the vulva!
dermatoses can present adjacent to premalignant and malignant lesions. It
seems therefore that it is difficult to guess from just inspecting the lesion, as
to whether the lesion is benign or not.
The modalities of treatment of these various conditions vary widely from
medical to surgical methods. It would therefore be inappropriate to treat
without biopsy or to biopsy the lesion randomly as there is a risk of not
obtaining the representative areas that can be achieved by doing vulvoscopy
or Collin's test. The aim of the study was therefore, firstly, to determine the
aetiology of white vulval skin lesions amongst patients attending the
gynaecological clinic at RK KHAN Hospital and secondly, to evaluate the
role of vulvoscopy and Collin's test.
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2. PATIENTS AND METHODS 
Ethical institutional permission was obtained and all patients gave informed
consent. The study was done over an 18-month period from January 1997 to
June 1998. All patients with white vulva! skin lesions as well as those patients
with similar lesions in other parts of the body were recruited for the study.
Initially an appropriate history was taken including complaints, age and parity. A
thorough general examination was done to exclude similar lesions elsewhere in
the body. The vulva was inspected and the distribution of the white skin lesion
recorded. If there was no vulvovaginal infection, vulvoscopy was done using the
method described by Hatch [1121 et al [1993]
Any abnormality detected by was noted and later biopsied as described below.
A Collin's test was then performed using 1% toludine blue, which was applied
to the vulval skin and washed off after 1 minute with 1% acetic acid. Those
areas, which retained the stain including those areas detected by vulvoscopy,
were selected for biopsy. The vulva was cleansed with antiseptic solution and
1 %I ignocaine was injected into the skin using a dental syringe.
These areas were then excised using a scalpel and sutures inserted where
necessary. All specimens were sent in formalin for histopathological assessment.
This was then followed by colposcopic assessment of the vagina and cervix and
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all abnormal areas were similiarly biopsied. Patients were given post operative
analgesia as well as antiseptic cream [ Povidine- Iodine] to apply to the biopsied
areas. A follow up visit was arranged 3 weeks later at which the histology results
and further management was discussed with the patients.
1. RESULTS
The findings of this descriptive study were analyzed by a qualified statistician
attached to the University of Natal Medical School, and are as follows:
1.1 CLINICAL FEATURES 
This study covered a period of 18 months and included 62 patients in total.
The mean age of the patients was 47.2 years [range 6 — 73]. The mean
parity was 2.5 [range 0 — 4]. The commonest presenting symptom was
pruritus vulvae [70%] [Table]. Only 18% of patients reported the presence
of a white vulva! skin lesion. In a small percentage of patients [1.7%], these
lesions were detected on routine gynaecological examination.
The majority of patients [94%] did not have similar lesions elsewhere in the
body, whilst 5% of patients also had similar skin lesions involving the trunk,
li mbs and abdomen in addition to the vulva! lesion. In 43% of patients, the
white skin involved the vulva and perineum with relative sparing of the area
in-between. This type of skin lesion was called the "Figure of 8" pattern. The
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remainder of the patients had white skin lesions involving the clitoris, labia
majora, labia minora, posterior fourchette and perineum, alone or in
combination.
1.2 INVESTIGATIONS 
The majority of patients [n = 47] had a benign pap smear of the cervix,
whilst 5 patients had human papillomavirus infection detected on pap smear.
Two patients had mild cervical intraepithelial neoplastic lesions [low-grade
squamous intraepithelial lesion] detected on smear and 2 patients had
acetowhite areas of the vulva detected on vulvoscopy.
Two patients had mild to severe grade cervical intraepithelial neoplastic
abnormalities detected on colposcopy. There were no abnormalities detected
on colposcopy of the vagina and no premalignant or malignant abnormalities
of the vulva. The Collin's test was positive in 40% of patients and the
commonest area in which this test was positive, was the posterior fourchette,
where it was noted that many of these patients had fissures. [Table II]
1.3 HISTOLOGICAL FEATURES 
The commonest histological diagnosis was lichen scleroses in 70% of
patients, with squamous cell hyperplasia being the second commonest
histological finding. [20%] Of the remaining patients, 9% had non —
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specific dermatitis and 1.7% had lichen simplex chronicus. None of the
patients had vulva! intraepithelial neoplasia or invasive carcinoma of the
vulva. [Table 111]
The commonest histological diagnosis across all age groups was lichen
sclerosus. Those patients who had white skin lesions involving other sites of
the body also had lichen sclerosus when it was also present on the vulva.
[N = 3] On comparing the pattern of white vulva! skin distribution with
histological diagnosis, it was found that those patients who had white skin
lesions in a "Figure of 8" distribution, also had lichen sclerosus on histology.
Two patients had cervical intraepithelial neoplasia [C1N] diagnosed
histologically. The 2 patients who had acetowhite areas detected on





The present study done over an 18 month period included 62 patients in
total, all of whom were of the Asiatic race group. Previous studies have
found that most of the vulva! dermatoses tend to occur mainly in Caucasian
groups, although, it has been documented in Black patients by Barclay ['let
al [1966] and Dogliotti ['I et al [1974]. Meyrick — ThomasE"let al
[1987] found lichen sclerosus to occur in 1% of Asian women in a study
involving 350 patients, although, here the study population consisted mainly
of White females. The reason for this racial predilection is as yet unknown.
Although RK Khan Hospital is situated in an area, which drains
predominantly Indians patients, many Black patients from surrounding areas
attend the hospital for medical attention.
The distribution of the patients with regards age varied widely with most of
this variation being accounted for by lesions detected in premenarchal girls
with lichen sclerosus. Only 7 patients [11°/o] were under the age of 30
years. The majority of patients were above the age of 50 years and the mean
age of all patients was 47.2 years. The occurrence of lichen sclerosus in
prepubertal females as well as postmenopausal females is similar to that
reported by Kaufman [391 et al [1994]. Majority of the patients with
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squamous cell hyperplasia were under the age of 50 years, in keeping with
that reported by Kaufman 
1391
 et al [1994].
The parity of all patients studied ranged from 0 — 4 and greater, whilst the
mean parity was 2.5. There is no evidence from the literature that there may
be any relationship between parity and the occurrence of white vulva! skin
lesions.
Only 18% of patients reported the presence of a white vulval skin lesion.
Here the lesion was either detected by their general practitioner or in a few
cases by the patients themselves. Most patients who noted the lesions
themselves did not present immediately. Reasons for this varied. Some
patients were embarrassed and therefore did not seek medical opinion, whilst
others thought that the lesion was harmless. This was in spite of the fact that
most of these lesions were associated with troublesome pruritus vulvae. The
presenting complaints varied with pruritus vulvae being the most frequent
[70%]. A very small percentage [1.7%] of patients were asymptomatic.
These findings are in keeping with that reported by Kaufman 
[391
 et al
[1994]. This stresses the need to carefully examine the vulva at every
gynaecological examination to detect asymptomatic lesions. It has been
shown that the prognosis of vulva! malignancies is better the earlier the lesion
is detected. "1 There were 3 patients[5%] who had white skin lesions
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involving the genitalia as well as extragenital sites. These lesions were usually
detected at routine examination. These findings concur with that of
Kaufman [391 et al [1994] who found the incidence of lichen sclerosus in
extragenital sites to be 3% in 200 women with genital lichen sclerosus.
White skin lesions can involve any site of the vulva. Whilst 43% of patients
had the so called "figure of 8" type distribution of white skin lesions, where
the lesion involved the vulva and perineum with relative sparing of the area
in-between, the majority of the remaining patients had white skin distribution
involving multiple random sites with no particular pattern. Although the
"figure of 8" pattern is classical of lichen sclerosus, some patients with varied
pattern of white vulva! skin distribution, also had lichen sclerosus on
histology. Thus, the clinical appearance of the white skin distribution
correlates with that described in the literature, with the exception that no
patients in the study with lichen sclerosus had phimosis or clitoral stenosis.
These features emphases the point that a diagnosis cannot be made by simply
inspecting the lesions macroscopically.
Vulvoscopy was done using a standard colposcope used for microscopic
examination of the cervix. Generally most lesions were covered with keratin
and only 2 patients had colposcopic evidence of human papilloma virus
infection, which was confirmed histologically. The limitation of vulvoscopy
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due to keratin has been reported by Reid 
[111] 
et al [1995]. In some patients
KY jelly was applied to the skin to reduce the reflection of the light from the
colposcope. However, there seemed to have been little improvement in this
respect. There were no specific vulvoscopic patterns noted in patients
diagnosed with vulva! dermatoses.
The Collin's test was positive in 40% of patients and the posterior fourchette
was the most common area to stain positive. Here it was noted that majority
of patients had fissures present which could have followed on scratching or
intercourse. It was noted histologically that those patients with positive
staining of the posterior fourchette had lichen sclerosus present. However,
this does not imply that the commonest site to find lichen sclerosus is the
posterior fourchette, as lichen sclerosus was also detected at other sites. This
is in keeping with the observations of Collin that areas devoid of epithelium,
exposing nuclear material would stain positive with application of toludine
blue. Some would interpret this findings as being "false positives".
However, Collin 
[141
 [1966] stated that this test is not a test to detect areas
with malignancy, but to select sites for biopsy in order to exclude malignancy
histologically. If random sites are biopsied without doing vulvoscopy or the
Collin's test, significant areas could be missed where premalignant or
malignant disease is present. These conditions frequently tend to be
multicentric and therefore the determination of the extent of the disease is
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vital to guide therapy. The histopathologists are also faced with a problem
when large random specimens are sent to them for assessment, as it may be
difficult to decide which part of the specimen to choose for histological
assessment.
Histological findings showed that lichen sclerosus was the commonest
diagnosis [70%] across all age groups, in keeping with that reported in the
literature [ "1 . The histological features supporting the diagnosis of lichen
sclerosus included: hyperkeratosis, epithelial thinning, flat or absent ret pegs,
follicular plugging, a homogenous acellular area beneath the epidermis and
an inflammatory cell infiltrate in some cases. Friedrich " 71 [1983] also
reported that lichen sclerosus was the commonest cause of white vulval skin
lesions, occurring in 70% of patients.
There were 13 patients with a histological diagnosis of squamous cell
hyperplasia. The features supporting this diagnosis included hyperkeratosis,
acanthosis or epithelial thickening, elongation and distortion of the rete pegs
and a chronic inflammatory cell infiltrate in the dermis. None of these
patients had any underlying dermatosis, which could have resulted in these
changes. The diagnosis of squamous cell hyperplasia was therefore made by
exclusion, as recommended by Wilkinson [461 [1992].
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Six patients in the study had non-specific dermatitis diagnosed histologically.
Histologically, it was found there were no specific features to arrive at a
specific diagnosis. The features consisted mainly of inflammatory cells as well
as perivascular inflammation in some cases. Non-specific dermatitis as the
histological finding in some patients with white vulval skin lesions, is not
commonly reported in the literature. 0' Keefe 
[371
 et al [1995] found the
incidence of non-specific dermatitis to be 6% in 114 patients studied.
There were no patients in the study with vulva! intraepithelial neoplasia or
vulva! invasive carcinoma. Of note is that the biopsy specimens were either
taken from areas found to stain with toludine blue or random sites when the
Collin's test was negative. In view of the negative vulvoscopic findings as well
as negative histological findings of those areas biopsied when the Collin's test
was positive, the role of vulvoscopy and the Collin's test may be questioned.
However, it must be remembered that the aim of these tests is to select areas
to biopsy to exclude malignant or premalignant lesions histologically and not
to diagnose such lesions by these tests directly.
The findings in this study confirm the fact that there are many different
causes of a white vulva! skin lesion. Since the treatment of the different
causes of white vulval skin lesions vary from medical to surgical, with surgery
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having its attendant problems, it is imperative that clinicians treat these
lesions based on histological findings.
2. CONCLUSIONS AND RECOMMENDATIONS 
A plethora of terms have been applied to lesions of the vulva, characterized
by shrinkage, whitening or reddening. Many such terms were used
interchangeably as clinical and histological descriptions. The looseness of such
terminology led to a wide variety of therapeutic modalities such as surgery
and radiotherapy, for conditions or unproven malignant potential. The
present study shows that the majority of white vulva! skin lesions are benign
in nature. This has been the reason why there has been uncertainty in the
past as regards the approach to these patients. There has been a tendency to
treat empirically without doing any investigations.
The approach adopted in this study and which is therefore recommended
should be to do a Pap smear, vulvoscopy, vaginoscopy, colposcopy, Collin's
test and directed biopsies of abnormal areas detected by these tests. In spite
of the limitations of these tests, we can expect premalignant areas to be
detected if they are present in a patient. The value of these tests is akin to
the practice of doing colposcopy and directed biopsies of the cervix if a
patient has an abnormal pap smear. Here, the implications are similar if a
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premalignant or malignant lesion is diagnosed in addition to the fact that
prognosis is better the earlier the diagnosis is made.
IN SPITE OF THE LIMITATIONS OF THESE TESTS AND THE FACT
THAT NO PATIENT IN THIS STUDY HAD PREMALIGNANT OR
MALIGNANT LESIONS, MY RECOMMENDATION TO DO THESE
TESTS CONCURS WITH THAT OF LEADING VULVOLOGISTS.117'19,911
TABLE I : PRESENTING COMPLAINTS
Pruritus vulvae 43 [70%]
White vulval skin 11 [l8%]
Vaginal discharge 21 [36%]
Post menopausal bleeding 1 [1.7%]
Hot flushes 2 [3.4%]
Generalized white skin of body 1 [1.7%]
Asymptomatic 1 [1.7%]
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TABLE II : RESULTS OF COLLIN'S TEST
Negative 35 [60%1
Positive 23 [40%1
No. of Positive Areas Site Diagnosis
2 Lower labia majora Lichen sclerosus
13 Posterior Fourchette Lichen sclerosus
3 Posterior Fourchette Squamous cell hyperplasia
2 Right/left labia majora Lichen sclerosus
1 Clitoris Squamous cell hyperplasia
2 Posterior Fourchette Non-specific dermatitis
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TABLE III : HISTOLOGICAL DIAGNOSIS OF ALL WHITE VULVAL SKIN 
LESIONS [n = 62] 
Lichen Sclerosus 43 [70%]
Squamous Cell Hyperplasia 13 [20%]
Non-specific Dermatitis 5 [9%]
Lichen Simplex Chronicus 1 [1.7%]




CLINICAL FEATURES OF LICHEN SCLEROSUS
Photograph shows white vulva! skin in a background of normal skin.
Note the peri- introital and peri-anal involvement.
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PHOTOGRAPH NUMBER 2
CLINICAL FEATURES OF SQUAMOUS CELL HYPERPLASIA
Photograph shows white vulval skin lesion involving multiple areas of the vulva
with no particular pattern.
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FIGURE 1
CLINICAL FEATURES OF LICHEN SIMPLEX CHRONICUS
Figure shows white leathery appearing vulva! skin
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FIGURE 2
CLINICAL FEATURES OF LICHEN PLANUS
This figure shows the erosive type of lichen planus as can be seen
in the region of the introitus where there is desquamation of the skin.
The skin surrounding this region appears white in colour. There is also a purplish-
white skin lesion noted in the surrounding areas which is typical of lichen planus.
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PHOTOGRAPH NUMBER 3
HISTOPATHOLOGICAL FEATURES OF LICHEN SCLEROSUS
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PHOTOGRAPH NUMBER 4
HISTOPATHOLOGICAL FEATURES OF SQUAMOUS CELL HYPERPLASIA
78
PHOTOGRAPH NUMBER 5
HISTOPATHOLOGICAL FEATURES OF LICHEN SIMPLEX CHRONICUS
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FIGURE 3
CLINICAL FEATURES OF VULVAL INTRAEPITHELIAL NEOPLASIA
The figure shows white vulva! skin lesion with areas of plaque formation
in a patient with vulva! intraepithelial neoplasia.
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PHOTOGRAPH NUMBER 6




CLINICAL FEATURES OF PAGET'S DISEASE OF THE VULVA
The figure shows white vulva! skin lesion scattered over a bright red base, typical of
Paget's disease of the vulva.
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PHOTOGRAPH NUMBER 7
HISTOPATHOLOGICAL FEATURES OF PAGET'S DISEASE OF THE VULVA
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FIGURE 5
CLINICAL FEATURES OF INVASIVE SQUAMOUS CELL CARCINOMA OF
THE VULVA
White vulval skin with areas of nodularity. This lesion cannot be clinically
differentiated from the other causes of white vulval skin lesions.
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PHOTOGRAPH NUMBER 8
HISTOPATHOLOGICAL FEATURES OF INVASIVE SQUAMOUS CELL





KEYES CUTANEOUS PUNCH BIOPSY INSTRUMENT
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